Cell Therapeutics' Pixuvri Could Be Stopped By Early Trial Termination
This article was originally published in The Pink Sheet Daily
Executive Summary
Advisory committee will consider whether the results for the non-Hodgkin's lymphoma treatment's Phase III trial, which suffered an unplanned early halt, are sufficient.